Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Maria Gabriella Matera, Barbara Rinaldi, Clive Page, Paola Rogliani & Mario Cazzola. (2018) Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Metabolism & Toxicology 14:10, pages 1101-1111.
Read now
Read now
Paola Rogliani, Maria Gabriella Matera, Josuel Ora, Mario Cazzola & Luigino Calzetta. (2017) The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3469-3485.
Read now
Read now
Maria Gabriella Matera, Alessandro Sanduzzi, Roberto Alfano & Mario Cazzola. (2016) Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema. Expert Review of Clinical Pharmacology 9:6, pages 771-777.
Read now
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
Read now
Luigino Calzetta, Chiara Ciaprini, Ermanno Puxeddu & Mario Cazzola. (2016) Olodaterol + tiotropium bromide for the treatment of COPD. Expert Review of Respiratory Medicine 10:4, pages 379-386.
Read now
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2015) Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:5, pages 529-539.
Read now
Read now
Cristoforo Incorvaia, Philippe Moingeon, Serena Buttafava & Franco Frati. (2015) Focusing the mechanism of action to dissect the different treatments of respiratory allergy. Expert Review of Clinical Immunology 11:9, pages 1005-1013.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2015) QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:7, pages 1079-1090.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani, Barbara Rinaldi & Mario Cazzola. (2015) Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:1, pages 35-41.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2015) Indacaterol for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:1, pages 107-115.
Read now
Read now
Andrea Segreti, Luigino Calzetta, Paola Rogliani & Mario Cazzola. (2014) Umeclidinium for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 8:6, pages 665-671.
Read now
Read now
Articles from other publishers (14)
Felisbela Gomes & Shih-Lung Cheng. (2023) Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System. Biomolecules 13:3, pages 476.
Crossref
Crossref
Sheikh Rayees & Inshah DinSheikh Rayees & Inshah Din. 2021. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions
19
25
.
Han Ni, Soe Moe, Zay Soe, Kay Thi Myint & K Neelakantan Viswanathan. (2018) Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Sid Ahmed Labed, Khursheed A. Wani, Sakthimala Jagadeesan, Abdul Hakkim, Mehran Najibi & Javier Elbio Irazoqui. (2018) Intestinal Epithelial Wnt Signaling Mediates Acetylcholine-Triggered Host Defense against Infection. Immunity 48:5, pages 963-978.e3.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2016) Tiotropium formulations and safety: a network meta-analysis. Therapeutic Advances in Drug Safety 8:1, pages 17-30.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Ermanno Puxeddu, Josuel Ora, Francesco Facciolo, Paola Rogliani & Maria Gabriella Matera. (2016) Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respiratory Research 17:1.
Crossref
Crossref
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2016) Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update. Drug Safety 39:6, pages 501-508.
Crossref
Crossref
Bing Han, Wilfred J. Poppinga, Haoxiao Zuo, Annet B. Zuidhof, I. Sophie T. Bos, Marieke Smit, Pieter Vogelaar, Guido Krenning, Robert H. Henning, Harm Maarsingh, Andrew J. Halayko, Bernard van Vliet, Stef Stienstra, Adrianus Cornelis van der Graaf, Herman Meurs & Martina Schmidt. (2016) The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease. Scientific Reports 6:1.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani, Ermanno Puxeddu, Francesco Facciolo & Maria Gabriella Matera. (2016) Interaction between corticosteroids and muscarinic antagonists in human airways. Pulmonary Pharmacology & Therapeutics 36, pages 1-9.
Crossref
Crossref
Maria Gabriella Matera & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD
41
62
.
Paola Rogliani, Luigino Calzetta, Josuel Ora, Roberto Lipsi, Andrea Segreti, Maria Gabriella Matera & Mario Cazzola. (2015) Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi. European Journal of Pharmacology 761, pages 383-390.
Crossref
Crossref
Barbara Rinaldi, Maria Donniacuo, Loredana Sodano, Giulia Gritti, Eugenio Martuscelli, Augusto Orlandi, Concetta Rafaniello, Francesco Rossi, Luigino Calzetta, Annalisa Capuano & Maria Gabriella Matera. (2015)
Effects of chronic treatment with the new ultra-long-acting β
2
-adrenoceptor agonist indacaterol alone or in combination with the β
1
-adrenoceptor blocker metoprolol on cardiac remodelling
. British Journal of Pharmacology 172:14, pages 3627-3637.
Crossref
Crossref
Han Ni, Soe Moe, Zay Soe, Kay Thi Myint & K Neelakantan Viswanathan. (2015)
Combined aclidinium bromide and long-acting beta
2
-agonist for COPD
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Graham F Cope. (2015) Long-acting medications for chronic obstructive pulmonary disease. British Journal of Healthcare Management 21:1, pages 18-20.
Crossref
Crossref